Open AccessFluoxetine for stroke recovery improvement – the doubleblind, randomised placebo-controlled FOCUS-Poland trial
Author(s) -
Jan Bembenek,
Maciej Niewada,
Bożena Kłysz,
Anna Mazur,
Katarzyna Kurczych,
Marcin Głuszkiewicz,
Anna Członkowska
Publication year - 2020
Publication title -
neurologia i neurochirurgia polska
Language(s) - English
Resource type - Journals
eISSN - 1897-4260
pISSN - 0028-3843
DOI - 10.5603/pjnns.a2020.0099
Subject(s) - medicine , fluoxetine , placebo , stroke (engine) , modified rankin scale , clinical trial , randomized controlled trial , odds ratio , adverse effect , confidence interval , cohort , physical therapy , ischemic stroke , mechanical engineering , alternative medicine , receptor , ischemia , pathology , serotonin , engineering
The Fluoxetine Or Control Under Supervision (FOCUS)-Poland trial tested in a Polish cohort the hypothesis that fluoxetine improves recovery after stroke.